Efficacy of the Anti‐Candida rAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis

Principles and Practice of Infectious Diseases.

(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,045 · see citing works

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · see citing works

Attributable Mortality of Nosocomial Candidemia, Revisited

Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · see citing works

The ALS gene family of Candida albicans.

Hoyer, L. L. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)01984-9 · Cited by 540 · see citing works

Functional and Structural Diversity in the Als Protein Family of Candida albicans

Sheppard, D. C., Yeaman, M. R., Welch, W. H., Phan, Q. T., Fu, Y., Ibrahim, A. S., Filler, S. G., Zhang, M., Waring, A. J., & Edwards, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401929200 · Cited by 300 · cited 4× · see citing works

Mice with Disseminated Candidiasis Die of Progressive Sepsis

Spellberg, B., Ibrahim, A. S., Edwards Jr., J. E., & Filler, S. G. (2005) · The Journal of Infectious Diseases · doi:10.1086/430952 · Cited by 230 · see citing works

Systemic Host Responses in Severe Sepsis Analyzed by Causative Microorganism and Treatment Effects of Drotrecogin Alfa (Activated)

Opal, S. M., Garber, G. E., LaRosa, S. P., Maki, D. G., Freebairn, R., Kinasewitz, G. T., Dhainaut, J.-F., Yan, S.-C. B., Williams, M. D., Graham, D. E., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375593 · Cited by 193 · see citing works

Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis

Fidel, P. L., Lynch, M. E., & Sobel, J. D. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4202-4207.1993 · Cited by 86 · see citing works

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity

Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83 · see citing works

Contribution of Candida albicans ALS1 to the Pathogenesis of Experimental Oropharyngeal Candidiasis

Kamai, Y., Kubota, M., Kamai, Y., Hosokawa, T., Fukuoka, T., & Filler, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5256-5258.2002 · Cited by 80 · see citing works

The Anti- Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice

Spellberg, B. J., Ibrahim, A. S., Avenissian, V., Filler, S. G., Myers, C. L., Fu, Y., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.6191-6193.2005 · Cited by 78 · see citing works

Parenchymal Organ, and Not Splenic, Immunity Correlates with Host Survival during Disseminated Candidiasis

Spellberg, B. J., Johnston, D. A., Phan, Q. T., Edwards, J. E., French, S. W., Ibrahim, A. S., & Filler, S. G. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5756-5764.2003 · Cited by 68 · see citing works

A phagocytic cell line markedly improves survival of infected neutropenic mice

Spellberg, B. J., Collins, M., French, S. W., Edwards, J. E., Fu, Y., & Ibrahim, A. S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205072 · Cited by 43 · see citing works

Genetic Susceptibility of Mice to Candida albicans Vaginitis Correlates with Host Estrogen Sensitivity

Clemons, K. V., Spearow, J. L., Parmar, R., Espiritu, M., & Stevens, D. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4878-4880.2004 · Cited by 42 · see citing works

The pathophysiology and treatment of Candida sepsis

Spellberg, B. J., & Edwards, J. E. (2002) · Current Infectious Disease Reports · doi:10.1007/s11908-002-0005-3 · Cited by 37 · see citing works

The Fungal Cell Wall: Structure, Biosynthesis, and Function

Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0035-2016 · Cited by 1,423 · see citing works

Vulvovaginal candidosis

Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270 · see citing works

Antifungal Drug Resistance: Molecular Mechanisms in <i>Candida albicans</i> and Beyond

Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801 · see citing works

<i>Candida</i> Infections of the Genitourinary Tract

Achkar, J. M., & Fries, B. C. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00076-09 · Cited by 736 · see citing works

Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells

Phan, Q. T., Myers, C. L., Fu, Y., Sheppard, D. C., Yeaman, M. R., Welch, W. H., Ibrahim, A. S., Edwards, J. E., & Filler, S. G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050064 · Cited by 641 · see citing works

Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors

Gonçalves, B., Ferreira, C., Alves, C. T., Henriques, M., Azeredo, J., & Silva, S. (2016) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1091805 · Cited by 669 · see citing works

COVID-19-associated fungal infections

Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482 · see citing works

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

Lin, L., Ibrahim, A., Xu, X., Farber, J., Avanesian, V., Baquir, B., Fu, Y., French, S., Edwards, J., & Spellberg, B. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000703 · Cited by 479 · see citing works

Architecture of the dynamic fungal cell wall

Gow, N. A. R., & Lenardon, M. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00796-9 · Cited by 447 · see citing works

An insight into the antifungal pipeline: selected new molecules and beyond

Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432 · see citing works

Infective endocarditis

Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miró, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 448 · see citing works

Immune responses to human fungal pathogens and therapeutic prospects

Lionakis, M. S., Drummond, R. A., & Hohl, T. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00826-w · Cited by 379 · see citing works

Importance of the Candida albicans cell wall during commensalism and infection

Gow, N. A., & Hube, B. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.04.005 · Cited by 347 · see citing works

Discovering the secrets of the<i>Candida albicans</i>agglutinin-like sequence (ALS) gene family – a sticky pursuit

Hoyer, L. L., Green, C. B., Oh, S.-H., & Zhao, X. (2008) · Medical Mycology · doi:10.1080/13693780701435317 · Cited by 356 · see citing works

Candida albicans Als3, a multifunctional adhesin and invasin

Liu, Y., & Filler, S. G. (2011) · Eukaryotic Cell · doi:10.1128/ec.00279-10 · Cited by 354 · see citing works

The Candida Pathogenic Species ComplexPreprint

Turner, S. A., & Butler, G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019778 · Cited by 337 · see citing works

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice

Liu, M., Spellberg, B. J., Phan, Q. T., Fu, Y., Fu, Y., Lee, A. S., Edwards, J. E., Filler, S. G., & Ibrahim, A. S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42164 · Cited by 326 · see citing works

Oral-resident natural Th17 cells and γδ T cells control opportunistic <i>Candida albicans</i> infections

Conti, H. R., Peterson, A. C., Brane, L., Huppler, A. R., Hernández-Santos, N., Whibley, N., Garg, A. V., Simpson-Abelson, M. R., Gibson, G. A., Mamo, A. J., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130877 · Cited by 254 · see citing works

Metals in fungal virulence

Gerwien, F., Skrahina, V., Kasper, L., Hube, B., & Brunke, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux050 · Cited by 246 · see citing works

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults

Schmidt, C. S., White, C. J., Ibrahim, A. S., Filler, S. G., Fu, Y., Yeaman, M. R., Edwards, J. E., & Hennessey, J. P. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.038 · Cited by 233 · see citing works

Advances in combating fungal diseases: vaccines on the threshold

Cutler, J. E., Deepe, G. S., & Klein, B. S. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1537 · Cited by 223 · see citing works

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

Edwards, J. E., Schwartz, M. M., Schmidt, C. S., Sobel, J. D., Nyirjesy, P., Schodel, F., Marchus, E., Lizakowski, M., DeMontigny, E. A., Hoeg, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy185 · Cited by 213 · see citing works

Mouse model of oropharyngeal candidiasis

Solis, N. V., & Filler, S. G. (2012) · Nature Protocols · doi:10.1038/nprot.2012.011 · Cited by 195 · see citing works

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance

Bino, L. D., Østerlid, K. E., Wu, D., Nonne, F., Romano, M. R., Codée, J. D. C., & Adamo, R. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00021 · Cited by 207 · see citing works

Adaptive immune responses to Candida albicans infection

Richardson, J. P., & Moyes, D. L. (2015) · Virulence · doi:10.1080/21505594.2015.1004977 · Cited by 206 · see citing works

Adaptive immunity induces mutualism between commensal eukaryotes

Ost, K. S., O’Meara, T. R., Stephens, W. Z., Chiaro, T. R., Zhou, H., Penman, J., Bell, R. S., Catanzaro, J., Song, D., Singh, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03722-w · Cited by 205 · see citing works

Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence

Torosantucci, A., Chiani, P., Bromuro, C., de Bernardis, F., Palma, A., Liu, Y., Mignogna, G., Maras, B., Colone, M., Stringaro, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005392 · Cited by 195 · see citing works

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

Luo, G., Lin, L., Ibrahim, A. S., Baquir, B., Pantapalangkoor, P., Bonomo, R. A., Doi, Y., Adams, M. D., Russo, T. A., & Spellberg, B. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029446 · Cited by 195 · see citing works

Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections

Hernández‐Santos, N., Huppler, A. R., Peterson, A. C., Khader, S. A., McKenna, K. C., & Gaffen, S. L. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.128 · Cited by 191 · see citing works

Covalently linked cell wall proteins of<i>Candida albicans</i>  and their role in fitness and virulence

Klis, F. M., Sosinska, G. J., de Groot, P. W. J., & Brul, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00541.x · Cited by 165 · see citing works

Advanced topical drug delivery system for the management of vaginal candidiasis

Johal, H. S., Garg, T., Rath, G., & Goyal, A. K. (2014) · Drug Delivery · doi:10.3109/10717544.2014.928760 · Cited by 158 · see citing works

Proteomics Unravels Extracellular Vesicles as Carriers of Classical Cytoplasmic Proteins in Candida albicans

Gil-Bona, A., Llama‐Palacios, A., Parra‐Giraldo, C. M., Vivanco, F., Nombela, C., Monteoliva, L., & Gil, C. (2014) · Journal of Proteome Research · doi:10.1021/pr5007944 · Cited by 151 · see citing works

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection

Singh, S., Uppuluri, P., Mamouei, Z., Alqarihi, A., Elhassan, H., French, S., Lockhart, S. R., Chiller, T., Edwards, J. E., & Ibrahim, A. S. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007460 · Cited by 162 · see citing works

The Protein Kinase Tor1 Regulates Adhesin Gene Expression in Candida albicans

Bastidas, R. J., Heitman, J., & Cardenas, M. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000294 · Cited by 154 · see citing works

Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders

Cassone, A., & Cauda, R. (2012) · AIDS (London) · doi:10.1097/qad.0b013e3283536ba8 · Cited by 163 · see citing works

Molecular and Cellular Mechanisms That Lead to Candida Biofilm Formation

ten Cate, J. M., Klis, F. M., Pereira‐Cenci, T., Wim Crielaard, A., & de Groot, P. W. J. (2009) · Journal of Dental Research · doi:10.1177/0022034508329273 · Cited by 150 · see citing works

The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus

Spellberg, B., Ibrahim, A., Yeaman, M., Lin, L., Fu, Y., Avanesian, V., Bayer, A., Filler, S., Lipke, P., Otoo, H., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00700-08 · Cited by 156 · see citing works

A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.

de Bernardis, F., Amacker, M., Arancia, S., Sandini, S., Gremion, C., Zurbriggen, R., Moser, C., & Cassone, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.069 · Cited by 128 · see citing works

Fungal vaccines, mechanism of actions and immunology: A comprehensive review

Nami, S., Mohammadi, R., Vakili, M., Khezripour, K., Mirzaei, H., & Morovati, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.075 · Cited by 136 · see citing works

IL-17 signaling in host defense against Candida albicans

Gaffen, S. L., Hernández‐Santos, N., & Peterson, A. (2011) · Immunologic Research · doi:10.1007/s12026-011-8226-x · Cited by 120 · see citing works

Fungal vaccines: real progress from real challenges

Cassone, A. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70016-1 · Cited by 112 · see citing works

Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile

Heilmann, C. J., Sorgo, A. G., Siliakus, A. R., Dekker, H. L., Brul, S., de Koster, C. G., de Koning, L. J., & Klis, F. M. (2011) · Microbiology · doi:10.1099/mic.0.049395-0 · Cited by 103 · see citing works

NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response

Ibrahim, A. S., Luo, G., Gebremariam, T., Lee, H.-K., Schmidt, C. S., Hennessey, J. P., French, S. W., Yeaman, M. R., Filler, S. G., & Edwards, J. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.016 · Cited by 97 · see citing works

Fungal cell wall: An underexploited target for antifungal therapies

Ibe, C., & Munro, C. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009470 · Cited by 99 · see citing works

Recent progress in vaccines against fungal diseases

Cassone, A., & Casadevall, A. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.04.004 · Cited by 90 · see citing works

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes

Lin, L., Tan, B., Pantapalangkoor, P., Ho, T., Hujer, A. M., Taracila, M. A., Bonomo, R. A., & Spellberg, B. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.11.008 · Cited by 91 · see citing works

Pathogenicity mechanisms and host response during oral Candida albicans infections

Hebecker, B., Naglik, J. R., Hube, B., & Jacobsen, I. D. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.916210 · Cited by 90 · see citing works

Fungal Cell Wall Proteins and Signaling Pathways Form a Cytoprotective Network to Combat Stresses

Ibe, C., & Munro, C. A. (2021) · Journal of Fungi · doi:10.3390/jof7090739 · Cited by 85 · see citing works

The Fungal Cell Wall: Structure, Biosynthesis, and Function

Gow, N. A. R., Latgé, J., & Munro, C. A. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch12 · Cited by 89 · see citing works

Innate immune cell response upon Candida albicans infection

Qin, Y.-L., Zhang, L., Xu, Z., Zhang, J.-Y., Jiang, Y.-Y., Cao, Y.-B., & Yan, T.-H. (2016) · Virulence · doi:10.1080/21505594.2016.1138201 · Cited by 79 · see citing works

Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis

Rudkin, F. M., Raziunaite, I., Workman, H., Essono, S., Belmonte, R. C., MacCallum, D. M., Johnson, E. M., Silva, L. M., Palma, A. S., Feizi, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07738-1 · Cited by 78 · see citing works

Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans

Luo, S., Skerka, C., Kurzai, O., & Zipfel, P. F. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.218 · Cited by 78 · see citing works

The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future

Tso, G. H. W., Reales‐Calderón, J. A., & Pavelka, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00897 · Cited by 79 · see citing works

Host–pathogen interactions and virulence-associated genes during Candida albicans oral infections

Martin, R., Wächtler, B., Schaller, M., Wilson, D., & Hube, B. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.04.009 · Cited by 78 · see citing works

Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection

Yeaman, M., Filler, S. G., Chaili, S., Barr, K., Wang, H.-Y., Kupferwasser, D., Hennessey, J., Fu, Y., Schmidt, C. S., Edwards, J. E., et al. (2014) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1415610111 · Cited by 26 · see citing works

Vaccines for invasive fungal infections

Spellberg, B. J. (2011) · F1000 Medicine Reports · doi:10.3410/m3-13 · Cited by 75 · see citing works

Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches

Janbon, G., Quintin, J., Lanternier, F., & d’Enfert, C. (2019) · Genes and Immunity · doi:10.1038/s41435-019-0071-2 · Cited by 71 · see citing works

Exploiting fungal cell wall components in vaccines

Levitz, S. M., Huang, H., Ostroff, G. R., & Specht, C. A. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0460-6 · Cited by 71 · see citing works

Antibody Titer Threshold Predicts Anti‐Candidal Vaccine Efficacy Even though the Mechanism of Protection Is Induction of Cell‐Mediated Immunity

Spellberg, B. J., Ibrahim, A. S., Lin, L., Avanesian, V., Fu, Y., Lipke, P. N., Otoo, H. N., Ho, T., & Edwards, J. E. (2008) · The Journal of Infectious Diseases · doi:10.1086/529204 · Cited by 69 · see citing works

Candida vaginitis: virulence, host response and vaccine prospects

Bernardis, F. D., Graziani, S., Tirelli, F., & Antonopoulou, S. (2017) · Medical Mycology · doi:10.1093/mmy/myx139 · Cited by 71 · see citing works

Novel strategies to fightCandidaspecies infection

Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 68 · see citing works

Metabolic Adaptations During Staphylococcus aureus and Candida albicans Co-Infection

Eichelberger, K. R., & Cassat, J. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.797550 · Cited by 65 · see citing works

Gene Overexpression/Suppression Analysis of Candidate Virulence Factors of Candida albicans

Fu, Y., Luo, G., Spellberg, B., Edwards, J., & Ibrahim, A. (2008) · Eukaryotic Cell · doi:10.1128/ec.00445-07 · Cited by 72 · see citing works

Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.

Luo, G., Ibrahim, A. S., French, S. W., Edwards, J. E., & Fu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025909 · Cited by 62 · see citing works

Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis

Villar, C. C., & Dongari‐Bagtzoglou, A. I. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000835 · Cited by 61 · see citing works

Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches

Janbon, G., Quintin, J., Lanternier, F., & d’Enfert, C. (2019) · Microbes and Infection · doi:10.1016/j.micinf.2019.06.011 · Cited by 61 · see citing works

Anticandidal Immunity and Vaginitis: Novel Opportunities for Immune Intervention

Cassone, A., de Bernardis, F., & Santoni, G. (2007) · Infection and Immunity · doi:10.1128/iai.00083-07 · Cited by 58 · see citing works

Mass spectrometric quantification of the adaptations in the wall proteome of Candida albicans in response to ambient pH

Sosinska, G. J., de Koning, L. J., de Groot, P. W. J., Manders, E. M. M., Dekker, H. L., Hellingwerf, K. J., de Koster, C. G., & Klis, F. M. (2010) · Microbiology · doi:10.1099/mic.0.044206-0 · Cited by 59 · see citing works

Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

Uppuluri, P., Singh, S., Alqarihi, A., Schmidt, C. S., Hennessey, J. P., Yeaman, M. R., Filler, S. G., Edwards, J. E., & Ibrahim, A. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01349 · Cited by 56 · see citing works

Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations

Pitman, S. K., Drew, R. H., & Perfect, J. R. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.607811 · Cited by 54 · see citing works

The contribution of mouse models to our understanding of systemic candidiasis: Modelling systemic Candida infection in mice

Szabo, E. K., & MacCallum, D. M. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02262.x · Cited by 59 · see citing works

Candida auris: A Continuing Threat

Bhargava, A., Klamer, K., Sharma, M., Ortiz, D. A., & Saravolatz, L. I. I. (2025) · Microorganisms · doi:10.3390/microorganisms13030652 · Cited by 58 · see citing works

Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins

Champer, J., Ito, J. I., Clemons, K. V., Stevens, D. A., & Kalkum, M. (2016) · Journal of Fungi · doi:10.3390/jof2010006 · Cited by 52 · see citing works

CRISPR-Based Genetic Manipulation of Candida Species: Historical Perspectives and Current Approaches

Uthayakumar, D., Sharma, J., Wensing, L. F., & Shapiro, R. S. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.606281 · Cited by 48 · see citing works

Novel strategies for the prevention and treatment ofCandidainfections: the potential of immunotherapy

van de Veerdonk, F. L., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., & Kullberg, B. J. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00232.x · Cited by 47 · see citing works

Studies of Immune Responses in Candida vaginitis

Bernardis, F. D., Arancia, S., Sandini, S., Graziani, S., & Norelli, S. (2015) · Pathogens · doi:10.3390/pathogens4040697 · Cited by 47 · see citing works

Immunosurveillance of Candida albicans commensalism by the adaptive immune system

Swidergall, M., & LeibundGut‐Landmann, S. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00536-5 · Cited by 47 · see citing works

Vaccines in the treatment of invasive candidiasis

Wang, X.-J., Sui, X., Yan, L., Wang, Y., Cao, Y.-B., & Jiang, Y.-Y. (2015) · Virulence · doi:10.4161/21505594.2014.983015 · Cited by 39 · see citing works

Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches

Chew, S. Y., & Than, L. T. L. (2016) · Mycoses · doi:10.1111/myc.12455 · Cited by 63 · see citing works

Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects

Lu, X., Zhou, J., Ming, Y., Wang, Y., He, R., Li, Y., Feng, L., Zeng, B., Du, Y., & Wang, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.013 · Cited by 48 · see citing works

New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges

Vecchiarelli, A., Pericolini, E., Gabrielli, E., & Pietrella, D. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00294 · Cited by 43 · see citing works

The role of diclofenac sodium in the dimorphic transition in Candida albicans.

Ghalehnoo, Z. R., Rashki, A., Najimi, M., & Domínguez, Á. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.12.003 · Cited by 42 · see citing works

The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans

Ferwerda, G., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Romani, L. R., & Kullberg, B. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.082 · Cited by 42 · see citing works

Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections

Lilly, E. A., Ikeh, M. A. C., Nash, E. E., Fidel, P. L., & Noverr, M. C. (2018) · mBio · doi:10.1128/mbio.01472-17 · Cited by 42 · see citing works

Saccharomycesas a Vaccine Against Systemic Candidiasis

Liu, M., Clemons, K. V., Johansen, M. E., Martinez, M., Chen, V., & Stevens, D. A. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.692418 · Cited by 42 · see citing works

In vivo targeting of human DC ‐ SIGN drastically enhances CD 8+ T ‐cell‐mediated protective immunity

Hesse, C., Ginter, W., Förg, T., Mayer, C. T., Baru, A. M., Arnold‐Schrauf, C., Unger, W. W. J., Kalay, H., van Kooyk, Y., Berod, L., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343429 · Cited by 41 · see citing works

Fungal Biofilms: Inside Out

Lagree, K., & Mitchell, A. P. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0024-2016 · Cited by 40 · see citing works

An Introduction to the Medically Important Candida Species

Moran, G. P., Coleman, D. C., & Sullivan, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch2 · Cited by 50 · see citing works

The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis

Shukla, M., Chandley, P., & Rohatgi, S. (2021) · Vaccines · doi:10.3390/vaccines9101159 · Cited by 43 · see citing works

FaaPred: A SVM-Based Prediction Method for Fungal Adhesins and Adhesin-Like Proteins

Ramana, J., & Gupta, D. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009695 · Cited by 40 · see citing works

Investigation of the Function of Candida albicans Als3 by Heterologous Expression in Candida glabrata

Fu, Y., Phan, Q. T., Luo, G., Solis, N. V., Liu, Y., Cormack, B. P., Edwards, J. E., Ibrahim, A. S., & Filler, S. G. (2013) · Infection and Immunity · doi:10.1128/iai.00013-13 · Cited by 37 · see citing works

Vaccines against candidiasis: Status, challenges and emerging opportunity

Sahu, S. R., Bose, S., Singh, M. K., Kumari, P., Dutta, A., Utkalaja, B. G., Patel, S. K., & Acharya, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1002406 · Cited by 41 · see citing works

From memory to antifungal vaccine design

Iannitti, R. G., Carvalho, A., & Romani, L. R. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.008 · Cited by 39 · see citing works

Moonlighting proteins induce protection in a mouse model against Candida species

Medrano-Díaz, C. L., Vega‐González, A., Ruiz‐Baca, E., Moreno, A., & Cuéllar‐Cruz, M. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.08.024 · Cited by 39 · see citing works

Current trends to control fungal pathogens: exploiting our knowledge in the host–pathogen interaction

García-Carnero, L. C., Pérez-García, L. A., Martínez-Álvarez, J. A., Reyes-Martínez, J. E., & Mora-Montes, H. M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s170337 · Cited by 38 · see citing works

Fungal Vaccines and ImmunotherapeuticsPreprint

Santos, E., & Levitz, S. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019711 · Cited by 38 · see citing works

Emerging drugs and vaccines for Candidemia

Moriyama, B., Gordon, L. A., McCarthy, M. W., Henning, S. A., Walsh, T. J., & Penzak, S. R. (2014) · Mycoses · doi:10.1111/myc.12265 · Cited by 38 · see citing works

The vaccines and antibodies associated with Als3p for treatment of Candida albicans infections.

Sui, X., Yan, L., & Jiang, Y.-Y. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.08.082 · Cited by 31 · see citing works

Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis.

Singh, S., Nabeela, S., Barbarino, A., Ibrahim, A. S., & Uppuluri, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.925821 · Cited by 34 · see citing works

Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris

Singh, S., Barbarino, A., Youssef, E. G., Coleman, D., Gebremariam, T., & Ibrahim, A. (2023) · Journal of Fungi · doi:10.3390/jof9010103 · Cited by 35 · see citing works

Efficacy of the Anti-Candida rAls3p-N or rAls1p-N Vaccines against Disseminated

Candidiasis, M., Spellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C. L., Phan, Q. T., Filler, S. G., Yeaman, M. R., & Edwards, J. E. (2006)

The Anti-Candida Vaccine Based on the Recombinant N-Terminal Domain of Als1p Is Broadly Active against Disseminated Candidiasis

Ibrahim, A., Spellberg, B., Avanesian, V., Fu, Y., & Edwards, J. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.3039-3041.2006 · Cited by 83 · see citing works

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity

Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83 · see citing works

The Anti- Candida albicans Vaccine Composed of the Recombinant N Terminus of Als1p Reduces Fungal Burden and Improves Survival in Both Immunocompetent and Immunocompromised Mice

Spellberg, B. J., Ibrahim, A. S., Avenissian, V., Filler, S. G., Myers, C. L., Fu, Y., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.6191-6193.2005 · Cited by 78 · see citing works

Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect. Immun

Ibrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005)